Penn Medicine Princeton Medical Center, formerly known as the University Medical Center of Princeton at Plainsboro, is a 355-bed non-profit, tertiary, and academic medical center located in Plainsboro Township, New Jersey, servicing the western New Jersey area and the Central Jersey area.

There are 308 beds in Penn Medicine - Princeton Health.

During the past decade, Penn Medicine - Princeton Health conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn Medicine - Princeton Health" #1 sponsor was "Radiation Therapy Oncology Group" with 9 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "ASTORA Women's Health" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "CancerVax Corporation" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn Medicine - Princeton Health" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Penn Medicine - Princeton Health" are "Prostate Cancer" (5 trials), "Breast Cancer" (2 trials), "Head and Neck Cancer" (2 trials), "Lung Cancer" (2 trials) and "Malignant Melanoma" (2 trials). Many other conditions were trialed in "Penn Medicine - Princeton Health" in a lesser frequency.

Most popular intervention types in "Penn Medicine - Princeton Health" are "Drug" (13 trials), "Other" (11 trials), "Radiation" (11 trials), "Biological" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (5 trials), "Laboratory Biomarker Analysis" (4 trials), "Placebo" (4 trials), "Quality-of-Life Assessment" (4 trials) and "Questionnaire Administration" (3 trials). Other intervention names were less common.

The vast majority of trials in "Penn Medicine - Princeton Health" are 20 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Penn Medicine - Princeton Health". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Penn Medicine - Princeton Health, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Penn Medicine - Princeton Health, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".